Sector consensus Vertex Pharmaceuticals Incorporated Sao Paulo
Stocks
VRTX34
BRVRTXBDR001
Pharmaceuticals
|
Delayed
Sao Paulo
18:35:19 06/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 77.25 BRL | -1.97% |
|
-10.03% | -1.27% |
| 09-28 | UBS Raises Vertex Pharmaceuticals Price Target to $615 From $585, Maintains Buy Rating | MT |
| 09-23 | TD Cowen Adjusts PT on Vertex Pharmaceuticals to $550 From $525, Maintains Buy Rating | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 1,328.83 | +16.25% | 29 | ||||||
| 279.5 | +10.5% | 22 | ||||||
| 278.86 | +4.93% | 28 | ||||||
| 156.36 | +12.05% | 25 | ||||||
| 375.66 | +7.67% | 19 | ||||||
| 151.69 | +8.24% | 22 | ||||||
| 209.57 | +34.74% | 23 | ||||||
| 390.94 | -2.99% | 29 | ||||||
| 158.65 | +9.7% | 26 | ||||||
| 307.56 | +24.62% | 23 | ||||||
| 28.91 | +5.49% | 26 | ||||||
| 571.39 | +13.48% | 28 | ||||||
| 66.12 | +12.44% | 24 | ||||||
| 979.36 | +6.98% | 14 | ||||||
| 94.06 | +34.39% | 24 | ||||||
| 21.73 | +23.53% | 21 | ||||||
| 120.67 | -40.62% | 18 | ||||||
| 853.19 | +17.44% | 26 | ||||||
| 154.21 | +13.35% | 14 | ||||||
| Average | 343.54 | +11.17% | 23 | ||||||
| Weighted average by Cap. | 498.04 | +11.92% | 25 |
Select your edition
All financial news and data tailored to specific country editions
